Some group of rogue traders drove the pps down as far as they could for one purpose only, to massively accumulate shares in preperatiion for regulatory meetings in the EU and the US in the coming weeks. Add that to the fact that RD continues to show that PRP has proven to be astonishingly successful in both halting metastatic dynamic of cancer and in treatment of pancreatic and ovarian cancers, followed by colorectal cancer. They are preparing to initiate Phase I human trials this year. Thus the rational for this group of traders to manipulate the pps down for maximum impact on upcoming news. Volume tells me that this is only the begining.....Do your own DD and glty
(1)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links